Stock Name: Healthway
Company Name: HEALTHWAY MEDICAL CORP LTD
DMG & Partners Research in a Mar 12 research report says: "Healthway has recorded dismal earnings growth over the past two years. That is set to change, as management is now focusing more on achieving sustainable growth for its clinics. With its new team of doctors establishing their patient base, patient loads are improving.
"Coupled with government initiatives (such as CHAS) to provide more accessible healthcare to the community, Healthway looks set to achieve steady revenue growth. It has not given up on expanding into China, where management believes the market has much potential.
"It will instead, adopt a more cautious approach, preferring to ensure existing clinics achieve growth before expanding further. Target price of 11.6 cents, implying a 26% upside from current levels. BUY (re-initiating coverage)."
Company Name: HEALTHWAY MEDICAL CORP LTD
| Research House: DMG | Price Call: BUY | Target Price: 0.116 |
DMG & Partners Research in a Mar 12 research report says: "Healthway has recorded dismal earnings growth over the past two years. That is set to change, as management is now focusing more on achieving sustainable growth for its clinics. With its new team of doctors establishing their patient base, patient loads are improving.
"Coupled with government initiatives (such as CHAS) to provide more accessible healthcare to the community, Healthway looks set to achieve steady revenue growth. It has not given up on expanding into China, where management believes the market has much potential.
"It will instead, adopt a more cautious approach, preferring to ensure existing clinics achieve growth before expanding further. Target price of 11.6 cents, implying a 26% upside from current levels. BUY (re-initiating coverage)."
